Hearing loss should be considered at the earliest stage of assessment for dementia.  It is essential for supporting patients and families, and it may prove important for treatment and risk reduction.

Dementia describes a clinical syndrome that encompasses difficulties in memory, language, and behaviour that leads to impairments in activities of daily living. Alzheimer’s disease is the most common subtype of dementia, followed by vascular dementia, mixed dementia, and dementia with Lewy bodies. Asthe global population is rapidly ages dementia has become a reater concern.  Worldwide the illness places considerable burden on individuals, their families, health and social care systems.

There is still much to learn about the possible causes of dementia, including Alzheimer's disease - the most common form of dementia. Developing better and more accurate methods of diagnosis is an important research focus. Currently there is no single test that can accurately diagnose dementia. This website also has many helpful tools and resources.

Antipsychotic medications are used to treat a variety of different mental health conditions. They may be used to treat people with dementia when they have certain serious behaviours that are hard to manage with other strategies. As a member of the care team, you have an important role to play in helping the health care providers decide whether this treatment is a good choice for your family member or friend. This guide will help you learn more about how antipsychotic medications are used to help people with dementia. 

This tool is designed to help providers understand, assess, and manage residents in LTC homes with behavioural and psychological symptoms of dementia (responsive behaviours), with a focus on antipsychotic medications. It was developed as part of Centre for Effective Practice’s Academic Detailing Service for LTC homes. This tool integrates best-practice evidence with clinical experience, and makes reference to relevant existing tools and services wherever possible. 

This tool is designed to help providers understand, assess, and manage residents in LTC homes with behavioural and psychological symptoms of dementia (responsive behaviours), with a focus on antipsychotic medications. It was developed as part of Centre for Effective Practice’s Academic Detailing Service for LTC homes. This tool integrates best-practice evidence with clinical experience, and makes reference to relevant existing tools and services wherever possible.

A joint MRC / Alzheimer’s Society / Alzheimer’s Research UK investment of £250M will create a national Institute which will bring together world-leading expertise in biomedical, care, public health and translational dementia research. Centred around the need for innovative, discovery science to unlock our understanding of the mechanisms underlying the development and progression of the dementias, the DRI’s research will invigorate the therapeutic pipeline and drive new approaches to diagnosis, treatment, care provision and prevention.

Dementia beginning before the age of 65 is known as young onset dementia (YOD). Many people assume that Alzheimer's disease and other dementias only affect older people. However, about 1 person in every 1,000 under the age of 65 develops dementia.

This 6 page reading list provides links to and summaries of a variety of open source resources including:

  • Online education
  • Resources to assist care partners
  • Information on different forms of dementia
  • Supports in South East Ontario

This guide provides a very general overview of the law and suggested practice for health practitioners in dealing with issues of incapacity to consent to treatment, admission to a long term care facility or manage property. It is not a legal opinion nor does it constitute legal advice. It does not include every detail contained in the law or the specific legal provisions that may apply in a particular case. For specific information about the law, please refer to the applicable statutes and consult your lawyer.

Pages